FINAL PROGRAM www.essm.org 10th Congress of the European ...
FINAL PROGRAM www.essm.org 10th Congress of the European ...
FINAL PROGRAM www.essm.org 10th Congress of the European ...
- No tags were found...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
poster presentationsPP-05-214Evaluation <strong>of</strong> <strong>the</strong> efficacy andsafety <strong>of</strong> Zydena ® (Udenafil) inmales with erectile dysfunctionand hypertension who are takingantihypertensive agentsJae-Seung Paick, Republic <strong>of</strong> KoreaS. W. Kim, Y. K. Park, J. S. Hyun,N. C. Park, S. W. Lee, K. H. Moon,W. S. ChungPP-05-215 Factors influencing patientsatisfaction after 12 months tadalafiltreatment: Results from <strong>the</strong>DETECT studyPetros Perimenis, GreeceT. Roumeguere, H. Heidler, E. Roos,M. Belger, H. SchmittPP-05-216PP-05-217PP-05-218Pharmacokinetic study <strong>of</strong> a noveltestosterone-in-adhesive matrixpatch during <strong>the</strong> 48 hours <strong>of</strong>application to hypogonadal menJean-Pierre Raynaud, FranceC. Aumonier, V. Gualano, D. Betea,A. Beckers, D. Stavros (Presenter)Response to first month tadalafiltreatment predicts 12 monthcontinuation in patients wi<strong>the</strong>rectile dysfunction : Results from<strong>the</strong> DETECT studyThierry Roumeguere, Belgiumb. verheyden, s. arver, a. bitton,t. eliasson, m. belger, h. schmittEffects <strong>of</strong> sildenafil on Sertoli cellsecretory functionNikolaos S<strong>of</strong>ikitis, GreeceN. Pardalidis, E. Grammeniatis,D. Giannakis, S. Gratsias, N. Giotitsas,S. Tsabalas, A. Gekas, P. Tsounapi,D. Baltogiannis, I. MiyagawaPP-05-219 Significant improvement inself esteem and relationshipquestionnaire scores in men wi<strong>the</strong>rectile dysfunction treated withSildenafil Citrate 50 mg or 100 mgVera Stecher, USAP. Stroberg, L.-J. TsengPP-05-220PP-05-221PP-05-222Treatment satisfaction in men usingflexible-dose versus 100-mg fixeddosesildenafil citrate for erectiledysfunctionVera Stecher, USAJ. Mulhall, L.-J. TsengSignificant Improvement in <strong>the</strong>erectile dysfunction inventory <strong>of</strong>treatment satisfaction questionnairescore in men with erectiledysfunction treated with SildenafilCitrate 50 mg or 100 mgPeter Stroberg, SwedenV. Stecher, L.-J. TsengSignificant improvement in <strong>the</strong>sexual experience questionnairescore in men with erectile dysfunctiontreated with SildenafilCitrate 50 mg or 100 mgPeter Stroberg, SwedenV. Stecher, L.-J. TsengPP-05-223 Giving patients with erectiledysfunction (ED) <strong>the</strong> opportunityto try all three available PDE-5 inhibitors will result in betterlongterm treatment compliance -results <strong>of</strong> a two year follow-upPeter Stroberg, SwedenC. Ljunggren, K. Salomonsson, H.HedelinPP-05-224PP-06Does <strong>the</strong> long-acting PDE5 inhibitortadalafil have longer-lasting ormore severe side-effects than <strong>the</strong>short-acting PDE5 inhibitors?Joby Taylor, United KingdomA. Storey, R. Walker, J. Cartledge,I. EardleyPoster PresentationsSurgery and Peyronie‘s diseasePP-06-225Distal hypospadias: Does it requiresurgical intervention?Robert Peters, United KingdomJ.C. Goddard, S. Tank, M. A. Khan45
Change language